Autolus Therapeutics plc ADR (NASDAQ: AUTL) is -3.65% lower on its value in year-to-date trading and has touched a low of $1.61 and a high of $7.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AUTL stock was last observed hovering at around $5.82 in the last trading session, with the day’s gains setting it 0.38%.
Currently trading at $6.20, the stock is 4.68% and -0.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.26 million and changing 6.62% at the moment leaves the stock 54.16% off its SMA200. AUTL registered 189.95% gain for a year compared to 6-month gain of 116.20%. The firm has a 50-day simple moving average (SMA 50) of $224.08 and a 200-day simple moving average (SMA200) of -$8.21.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -12.36% loss in the last 1 month and extending the period to 3 months gives it a 24.85%, and is 14.70% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.87% over the week and 6.89% over the month.
Autolus Therapeutics plc ADR (AUTL) has around 399 employees, a market worth around $1.08B and $1.70M in sales. Profit margin for the company is -12272.26%. Distance from 52-week low is 285.40% and -16.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-91.60%).
Autolus Therapeutics plc ADR quarterly earnings per share for the current quarter are estimated at -$0.25.The EPS is expected to grow by 38.63% this year, but quarterly earnings will post 1,954.20% year-over-year.
Autolus Therapeutics plc ADR (AUTL) Top Institutional Holders
124 institutions hold shares in Autolus Therapeutics plc ADR (AUTL), with institutional investors hold 76.04% of the company’s shares. The shares outstanding are 173.07M, and float is at 147.84M with Short Float at 1.87%. Institutions hold 60.34% of the Float.
The top institutional shareholder in the company is Syncona Portfolio Ltd with over 21.35 million shares valued at $50.81 million. The investor’s holdings represent 12.29% of the AUTL Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackstone Inc with 20.49 million shares valued at $48.76 million to account for 11.79% of the shares outstanding. The other top investors are Deep Track Capital, Lp which holds 15.0 million shares representing 8.64% and valued at over $35.7 million, while TFG Asset Management GP Ltd holds 6.91% of the shares totaling 12.0 million with a market value of $28.56 million.
